Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the T-Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Adaptimmune
Juno Therapeutics
Unum Therapeutics
Takara Bio
Altor Bioscience Corporation
Cellectis
Kite Pharma
Novartis
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
CAR-T
TCR
TIL Therapies
Application:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 T-Cell Immunotherapy Industry Overview
-
1.1.1 T-Cell Immunotherapy Market Scope and Market Segments
-
1.1.2 T-Cell Immunotherapy Industry Characteristics
-
1.1.3 Global and China T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
1.2 Global T-Cell Immunotherapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 CAR-T
-
1.2.2 TCR
-
1.2.3 TIL Therapies
-
1.3 Global T-Cell Immunotherapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Stomach Cancer
-
1.3.2 Lung Cancer
-
1.3.3 Colorectal Cancer
-
1.3.4 Esophagus Cancer
-
1.3.5 Pancreatic Cancer
-
1.3.6 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global T-Cell Immunotherapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 T-Cell Immunotherapy Industry Porter's Five Forces Model Analysis
-
2.2.3 T-Cell Immunotherapy Industry PEST Analysis
-
2.3 T-Cell Immunotherapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 T-Cell Immunotherapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on T-Cell Immunotherapy Industry
Chapter 3 Global and China T-Cell Immunotherapy Market, by Manufacturer
-
3.1 Global and China T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China T-Cell Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China T-Cell Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China T-Cell Immunotherapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China T-Cell Immunotherapy Market Top 3 Players
Chapter 4 Global and China T-Cell Immunotherapy Market, by Type (2017-2028)
-
4.1 T-Cell Immunotherapy Market Trend, by Type
-
4.2 Global T-Cell Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global T-Cell Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global T-Cell Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
4.3 China T-Cell Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China T-Cell Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China T-Cell Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China T-Cell Immunotherapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China T-Cell Immunotherapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global T-Cell Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global T-Cell Immunotherapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China T-Cell Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China T-Cell Immunotherapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global T-Cell Immunotherapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America T-Cell Immunotherapy Market Analysis
-
7.1 North America T-Cell Immunotherapy Market, by Type
-
7.2 North America T-Cell Immunotherapy Market, by Application
-
7.3 North America T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
7.3.1 United States T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe T-Cell Immunotherapy Market Analysis
-
8.1 Europe T-Cell Immunotherapy Market, by Type
-
8.2 Europe T-Cell Immunotherapy Market, by Application
-
8.3 Europe T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
8.3.1 Germany T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC T-Cell Immunotherapy Market Analysis
-
9.1 APAC T-Cell Immunotherapy Market, by Type
-
9.2 APAC T-Cell Immunotherapy Market, by Application
-
9.3 APAC T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
9.3.1 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa T-Cell Immunotherapy Market Analysis
-
10.1 Latin America, Middle East and Africa T-Cell Immunotherapy Market, by Type
-
10.2 Latin America, Middle East and Africa T-Cell Immunotherapy Market, by Application
-
10.3 Latin America, Middle East and Africa T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China T-Cell Immunotherapy Company Profiles
-
11.1 Adaptimmune
-
11.1.1 Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Adaptimmune T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.1.3 Adaptimmune T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Juno Therapeutics
-
11.2.1 Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Juno Therapeutics T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.2.3 Juno Therapeutics T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Unum Therapeutics
-
11.3.1 Unum Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Unum Therapeutics T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.3.3 Unum Therapeutics T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Takara Bio
-
11.4.1 Takara Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Takara Bio T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.4.3 Takara Bio T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Altor Bioscience Corporation
-
11.5.1 Altor Bioscience Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Altor Bioscience Corporation T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.5.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Cellectis
-
11.6.1 Cellectis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Cellectis T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.6.3 Cellectis T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Kite Pharma
-
11.7.1 Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Kite Pharma T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.7.3 Kite Pharma T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Novartis
-
11.8.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Novartis T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.8.3 Novartis T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 T-Cell Immunotherapy Industry Investment Prospect and Risk Assessment
-
12.1 T-Cell Immunotherapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 T-Cell Immunotherapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure China T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of CAR-T (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TCR (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer (2017-2028)
-
Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China T-Cell Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China T-Cell Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China T-Cell Immunotherapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China T-Cell Immunotherapy Market Share, by Manufacturer in 2021
-
Figure Global and China T-Cell Immunotherapy Market Share, by Manufacturer in 2022
-
Table Global T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Global T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Value, by Type (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure Global T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
Table China T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table China T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table China T-Cell Immunotherapy Sales Value, by Type (2017-2028)
-
Table China T-Cell Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure China T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Global T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Value, by Application (2017-2028)
-
Table Global T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure Global T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Table China T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table China T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table China T-Cell Immunotherapy Sales Value, by Application (2017-2028)
-
Table China T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Table North America T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table North America T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure North America T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table North America T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table North America T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure North America T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure United States T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Europe T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Europe T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Europe T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Europe T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure UK T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure France T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure France T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table APAC T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table APAC T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table APAC T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table APAC T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure India T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure India T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Adaptimmune Product Profiles, Application and Specification
-
Table Adaptimmune T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Juno Therapeutics Product Profiles, Application and Specification
-
Table Juno Therapeutics T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Unum Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Unum Therapeutics Product Profiles, Application and Specification
-
Table Unum Therapeutics T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takara Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takara Bio Product Profiles, Application and Specification
-
Table Takara Bio T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Altor Bioscience Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Altor Bioscience Corporation Product Profiles, Application and Specification
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cellectis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cellectis Product Profiles, Application and Specification
-
Table Cellectis T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kite Pharma Product Profiles, Application and Specification
-
Table Kite Pharma T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
